Equities Research Analysts’ updated eps estimates for Friday, November 3rd:

Apple (NASDAQ:AAPL) had its buy rating reissued by analysts at Citigroup Inc.. The firm currently has a $200.00 price target on the stock. They noted that the move was a valuation call. The analysts noted that the move was a valuation call.

Acacia Communications (NASDAQ:ACIA) had its buy rating reaffirmed by analysts at Needham & Company LLC. The analysts wrote, “Though 3Q17 results beat expectations, Acacia issued cautious 4Q17 guidance reflecting low visibility into the timing of China provincial network build-outs and seasonality in the DCI segment. While the company awaits a resumption in orders, it continues to invest heavily in new products to maintain its industry leadership position. New products including its CFP2 ACO, CFP2 DCO and silicon PIC will all ramp in 2H17 and the CFP2 ACO and DCO products should reach 10% of 2H17 sales. ACIA’s 1.2Tbps AC1200 solution remains on track to ramp in 2H18.””

Almost Family (NASDAQ:AFAM) had its buy rating reaffirmed by analysts at Jefferies Group LLC. The firm currently has a $58.00 target price on the stock.

AutoNation (NYSE:AN) had its hold rating reissued by analysts at Jefferies Group LLC. The firm currently has a $50.00 target price on the stock.

Ares Capital Corporation (NASDAQ:ARCC) had its buy rating reaffirmed by analysts at Jefferies Group LLC. Jefferies Group LLC currently has a $19.50 price target on the stock.

Ares Capital Corporation (NASDAQ:ARCC) had its buy rating reissued by analysts at National Securities. The firm currently has a $19.00 price target on the stock. The analysts wrote, “• ARCC posted core NII/share of $0.36, a penny shy of our estimate but exceeding consensus estimates of $0.35. The past two quarters since the purchase of ACAS, ARCC’s dividend coverage has improved and with the fee waivers in place for up to ten quarters since the purchase, we continue to expect dividend coverage to improve as the remaining $875 million of ACAS assets on the block are sold and recycled into higher yielding investments.

• Management identified the non-core assets as having a weighted average yield of 7.6% and the yield by cost on ARCC’s debt and other income producing securities was 9.6% in 3Q17. As the rotation into direct originations from the disposition of ACAS assets continues Ares will also have the benefit of increased capital structuring fees. Despite a frothy and complacent market, we think that many reputable sponsors not only value but require certainty of closing on large transactions.

• With the complete exit of the SSLP the 30% basket at Ares freed up substantially, with the new SDLP only 3.7% of the portfolio at cost with a 14.0% yield by cost as of 9/30/17. While it remains unclear of whether ARCC can expedite the ramping of this by placing the purchased SSLP loans into the new JV, we nonetheless expect the company to continue to steadily allocate capital to the SDLP which would serve to augment the yield on the portfolio considerably when contrasted with yields on both ACAS and proprietary assets in the portfolio.

• We are maintaining our 2017 core NII/share estimate of $1.46 and are revising our 2018 core NII/share estimate to $1.61 from $1.65.”

Aviva plc (LON:AV) had its overweight rating reaffirmed by analysts at Morgan Stanley. The firm currently has a GBX 670 ($8.84) price target on the stock.

Axovant Sciences (NYSE:AXON) had its sell rating reissued by analysts at Chardan Capital. They currently have a $3.00 price target on the stock.

Bravo Brio Restaurant Group (NASDAQ:BBRG) had its hold rating reissued by analysts at Jefferies Group LLC. The firm currently has a $2.50 target price on the stock.

bluebird bio (NASDAQ:BLUE) had its hold rating reissued by analysts at Jefferies Group LLC. They currently have a $130.00 price target on the stock.

Boot Barn Holdings (NYSE:BOOT) had its buy rating reiterated by analysts at Jefferies Group LLC. Jefferies Group LLC currently has a $13.00 price target on the stock.

Cabot Corporation (NYSE:CBT) had its buy rating reiterated by analysts at Jefferies Group LLC. Jefferies Group LLC currently has a $74.00 price target on the stock.

Cogent Communications Holdings (NASDAQ:CCOI) had its underperform rating reiterated by analysts at Raymond James Financial, Inc..

Tableau Software (NYSE:DATA) had its hold rating reiterated by analysts at Jefferies Group LLC. The firm currently has a $67.00 target price on the stock.

Discovery Communications (NASDAQ:DISCA) had its hold rating reissued by analysts at Jefferies Group LLC. Jefferies Group LLC currently has a $20.00 target price on the stock.

Dicerna Pharmaceuticals (NASDAQ:DRNA) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $10.00 price target on the stock, up from their previous price target of $6.00.

Engility Holdings (NYSE:EGL) had its hold rating reissued by analysts at Maxim Group. The analysts wrote, “EGL reported revenue of $487 million for 3Q17, which represents a 5% year- over-year decline and about $8 million below our estimate.””

EPAM Systems (NYSE:EPAM) had its buy rating reiterated by analysts at UBS AG. The firm currently has a $105.00 target price on the stock, up from their previous target price of $96.00.

FARO Technologies (NASDAQ:FARO) had its buy rating reissued by analysts at Noble Financial.

Frank’s International N.V. (NYSE:FI) had its hold rating reaffirmed by analysts at Jefferies Group LLC. The firm currently has a $7.50 target price on the stock.

Financial Engines (NASDAQ:FNGN) had its underperform rating reissued by analysts at Raymond James Financial, Inc..

GenMark Diagnostics (NASDAQ:GNMK) had its market perform rating reaffirmed by analysts at Raymond James Financial, Inc..

H&T Group Plc (LON:HAT) had its not rated rating reaffirmed by analysts at N+1 Singer.

H&T Group Plc (LON:HAT) had its add rating reiterated by analysts at Numis Securities Ltd. The firm currently has a GBX 375 ($4.95) target price on the stock.

Mednax (NYSE:MD) had its hold rating reiterated by analysts at Jefferies Group LLC. Jefferies Group LLC currently has a $44.00 target price on the stock.

Molina Healthcare (NYSE:MOH) had its hold rating reiterated by analysts at Jefferies Group LLC. Jefferies Group LLC currently has a $74.00 price target on the stock.

Newell Brands (NYSE:NWL) had its market perform rating reiterated by analysts at Raymond James Financial, Inc..

Potbelly Corporation (NASDAQ:PBPB) had its hold rating reissued by analysts at Maxim Group. They currently have a $11.00 price target on the stock. The analysts wrote, “Potbelly (PBPB) announced 3Q17 (September) pro forma EPS of $0.07, which matched our $0.07 estimate and was above the $0.06 Street mean. However, PBPB’s same-restaurant sales of -4.8% were below our -3.5% estimate but in line with the -4.8% Street mean. Management maintained 2017 pro forma EPS guidance of $0.30-$0.33, as well as its forecasts for same-restaurant sales and new unit growth.””

Aratana Therapeutics (NASDAQ:PETX) had its buy rating reissued by analysts at Jefferies Group LLC. The firm currently has a $8.00 target price on the stock.

Patagonia Gold plc (LON:PGD) had its not rated rating reaffirmed by analysts at Shore Capital.

Premier Global Infrastructure Trust PLC (LON:PGIT) had its corporate rating reissued by analysts at N+1 Singer.

Papa John’s International (NASDAQ:PZZA) had its hold rating reiterated by analysts at Jefferies Group LLC. They currently have a $65.00 price target on the stock.

Rowan Companies PLC (NYSE:RDC) had its hold rating reiterated by analysts at Jefferies Group LLC. The firm currently has a $15.00 target price on the stock.

Randgold Resources Limited (LON:RRS) had its buy rating reissued by analysts at Investec. Investec currently has a GBX 9,000 ($118.76) price target on the stock.

Safe Bulkers (NYSE:SB) had its hold rating reaffirmed by analysts at Jefferies Group LLC.

Smith & Nephew plc (LON:SN) had its hold rating reiterated by analysts at Berenberg Bank. They currently have a GBX 1,340 ($17.68) price target on the stock.

Snap-On (NYSE:SNA) had its hold rating reiterated by analysts at Jefferies Group LLC. They currently have a $175.00 price target on the stock.

Snap (NYSE:SNAP) had its hold rating reaffirmed by analysts at Wedbush. They currently have a $12.00 target price on the stock.

TESARO (NASDAQ:TSRO) had its hold rating reiterated by analysts at Jefferies Group LLC. Jefferies Group LLC currently has a $124.00 target price on the stock.

T2 Biosystems (NASDAQ:TTOO) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $8.00 target price on the stock.

Veeco Instruments (NASDAQ:VECO) had its buy rating reaffirmed by analysts at Benchmark Co.. The firm currently has a $23.00 price target on the stock.

Vulcan Materials (NYSE:VMC) had its hold rating reiterated by analysts at Jefferies Group LLC.

Wacker Chemie AG (ETR:WCH) had its neutral rating reiterated by analysts at DZ Bank AG.

Wright Medical Group N.V. (NASDAQ:WMGI) had its buy rating reaffirmed by analysts at Jefferies Group LLC.

Yum! Brands (NYSE:YUM) had its positive rating reaffirmed by analysts at UBS AG. They currently have a $89.00 price target on the stock, up from their previous price target of $83.00.

Zimmer Biomet Holdings (NYSE:ZBH) had its buy rating reaffirmed by analysts at Jefferies Group LLC. They currently have a $136.00 target price on the stock.

Receive News & Ratings for Apple Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apple Inc and related companies with MarketBeat.com's FREE daily email newsletter.